D-0096-2026 Class II Ongoing
FDA drug recall D-0096-2026 was initiated by Lannett Company Inc. on Oct 10, 2025 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 46,848 90-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 29, 2025
- Initiation Date
- Oct 10, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 46,848 90-count bottles
Product description
Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide in the USA
Code information
Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A, Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0096-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026